No changes in lipid profiles

What were the current and earlier numbers, and when you say cycle what exactly did that involve?

I tapered off Reta after six months, so I guess that counts as a cycle. Still, I have not seen any heart-health or lipid gains at all even though I exercised and adjusted my eating the entire time.

The weight came off, but lipid numbers can need more time to follow. While fat is actively breaking down, extra lipids enter the bloodstream. GLP-1s have been shown to help lipid profiles, yet the shift tends to happen slowly rather than right away. Good work finishing the cycle and reducing the extra weight. Many stay on these medications long term because benefits extend past the scale. My own LDL and triglycerides needed more than a year to reach healthy ranges, and fasting insulin took even longer. Even after holding the same weight for months, my metabolism kept improving.

I would not worry about trying a statin. There used to be a lot of negative talk, but newer options like pitavastatin and ezetimibe work well and both are now generic.

My cholesterol was never high yet I still ended up with multiple stents. I have taken forty milligrams of Rosuvastatin for years and added a PCSK9 inhibitor every two weeks after the last stent. My LDL now sits in the low twenties.

If someone took a statin for six months then stopped, would LDL be expected to differ from the starting point? Reta can lower LDL through greater liver uptake while it is being used. Once stopped, that effect ends. The separate question of whether a twenty-five-pound loss should have changed LDL remains reasonable, though it is unclear how directly that ties back to the medication itself.

Reta corrected my numbers in four to five weeks and brought every lipid value into range after they had been well outside it. I was also doing daily cardio and lifting along with a clean diet. Even starting TRT, which can raise lipids, did not prevent the improvement, and blood pressure, heart rate, and A1c all dropped as well.

My lipids have generally been decent except for elevated LDL. After twelve months on tirzepatide and four months on Reta while finishing the last of the weight, LDL finally fell below one hundred for the first time I recall. HDL now runs in the nineties and triglycerides were last at sixty. Tirzepatide helped, but I think Reta contributed more.

Genetic differences can override any lipid benefit from GLP-1 drugs. This mainly involves how many LDL-clearing receptors the liver has and how much PCSK9 protein is present, since that protein removes the receptors. GLP-1s work in part by raising receptor numbers, but high PCSK9 can limit the effect. If statins or ezetimibe do not help, elevated PCSK9 could be the cause and a different medication might be needed. An animation explains how the receptors and PCSK9 interact.